Onco-Innovations Limited (ONCO) | Finanzwire

Basculer en Français

8420	Companies
124079	Keywords
62429	Articles
66656	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

BRIEF

published on 01/09/2025 at 22:50, 1 hour 52 minutes ago

Onco-Innovations' New Technology May Enhance Cancer Treatment

Clinical Trials Cancer Treatment Radiation Therapy Onco-Innovations DNA Repair
PRESS RELEASE

published on 01/09/2025 at 22:45, 1 hour 57 minutes ago

Onco-Innovations' Technology Shown in Study to Successfully Inactivate DNA Repair in Cancer, Potentially Boosting Radiation Therapy Effectiveness
Onco-Innovations Limited announces exclusive PNKP inhibitors Technology for cancer treatment, potentially improving patient outcomes

Technology Patient Outcomes Cancer Treatment PNKP Inhibitors Onco-Innovations Limited
BRIEF

published on 01/09/2025 at 01:05, 23 hours 37 minutes ago

Onco-Innovations Secures Exclusive License for PNKP Inhibitors in Cancer Treatment

Cancer Treatment Oncology Market FDA Trials Onco-Innovations PNKP Inhibitors
PRESS RELEASE

published on 01/09/2025 at 01:00, 23 hours 42 minutes ago

Onco-Innovations Provides Information Regarding Exclusive License for Patented Drug with Potential to Enhance Cancer Treatment Options
Onco-Innovations Limited announces exclusive-licensed PNKP inhibitors Technology targeting cancer cells to enhance treatment effectiveness across various cancer types including colorectal, breast, and lung cancer

Clinical Trials Cancer Treatment Oncology Market Onco-Innovations Limited PNKP Inhibitors Technology

Accesswire

Published on 01/10/2025 at 00:00, 42 minutes ago

MedMira Receives Investigational Testing Authorization for its Multiplo(R) Complete Syphilis (TP/nTP) Antibody Test
Published on 01/09/2025 at 23:05, 1 hour 37 minutes ago

Caldwell Reports First Quarter Results
Published on 01/09/2025 at 22:45, 1 hour 57 minutes ago

Onco-Innovations' Technology Shown in Study to Successfully Inactivate DNA Repair in Cancer, Potentially Boosting Radiation Therapy Effectiveness
Published on 01/09/2025 at 22:00, 2 hours 42 minutes ago

Vision Marine Technologies Innovates HV Marine Battery Packs in Collaboration With Calip Group
Published on 01/09/2025 at 21:00, 3 hours 42 minutes ago

CAGE Bio Announces Phase 2b Trial for CGB-500 (1% Tofacitinib), a Breakthrough Topical JAK Inhibitor for Moderate to Severe Atopic Dermatitis

View all ACCESSWIRE

EQS Group

Published on 01/09/2025 at 20:28, 4 hours 13 minutes ago

EQS-Adhoc: DATAGROUP will not pursue the spin-off of its subsidiary Almato AG
Published on 01/09/2025 at 20:20, 4 hours 21 minutes ago

EQS-Adhoc: Shelly Group announces preliminary consolidated sales revenues FY 2024
Published on 01/09/2025 at 18:25, 6 hours 16 minutes ago

AMUNDI ETF** – Important Information – Replication Change – 03/03/2025
Published on 01/09/2025 at 18:06, 6 hours 35 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 01/09/2025 at 18:00, 6 hours 41 minutes ago

LLB successfully concludes acquisition of ZKB Austria

Les Echos

Published on 01/09/2025 at 18:00, 6 hours 42 minutes ago

Imerys-09_01_2025-information-share-capital-and-voting-rights-as-of-30-November-2024
Published on 01/09/2025 at 17:45, 6 hours 57 minutes ago

Safran - Share buyback for cancellation
Published on 01/09/2025 at 17:45, 6 hours 57 minutes ago

Half-year liquidity contract statement December 31, 2024
Published on 01/09/2025 at 17:45, 6 hours 57 minutes ago

CHARGEURS - Half-year statement of the liquidity contract H2 2024
Published on 01/09/2025 at 07:00, 17 hours 41 minutes ago

OVHcloud confirms its 2025 financial guidance, driven by a good start to the year, with organic growth of +10.1% in the first quarter

View all LES ECHOS COMFI WIRE